Page last updated: 2024-11-03

opc 12759 and Benign Mucosal Pemphigoid

opc 12759 has been researched along with Benign Mucosal Pemphigoid in 1 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Research Excerpts

ExcerptRelevanceReference
"Long-term treatment with topical rebamipide and diquafosol can improve dry eye in patients with cGVHD or OCP-like disease."7.81Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. ( Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M, 2015)
"Long-term treatment with topical rebamipide and diquafosol can improve dry eye in patients with cGVHD or OCP-like disease."3.81Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. ( Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamane, M1
Ogawa, Y1
Fukui, M1
Kamoi, M1
Saijo-Ban, Y1
Yaguchi, S1
Mukai, S1
Kawakita, T1
Simmura, S1
Tsubota, K1

Other Studies

1 other study available for opc 12759 and Benign Mucosal Pemphigoid

ArticleYear
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Optometry and vision science : official publication of the American Academy of Optometry, 2015, Volume: 92, Issue:4 Suppl 1

    Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibit

2015